Testosterone/dutasteride

Testosterone/dutasteride is a combination formulation of testosterone, an androgen, and dutasteride, a 5α-reductase inhibitor, which was under development by GlaxoSmithKline for the treatment of hypogonadism (low testosterone levels) in men in the 2000s.[1] It reached phase II clinical trials prior to the discontinuation of its development.[1]

Testosterone/dutasteride
Combination of
TestosteroneAndrogen
Dutasteride5α-Reductase inhibitor
Clinical data
Other namesDutasteride/testosterone

References
  1. http://adisinsight.springer.com/drugs/800023906



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.